Ascentage Pharma Files Routine 6-K Report
Ticker: AAPG · Form: 6-K · Filed: Mar 6, 2025 · CIK: 2023311
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
Related Tickers: 002555.HK
TL;DR
Ascentage Pharma (002555.HK) filed a standard 6-K, no new info.
AI Summary
Ascentage Pharma Group International filed a Form 6-K on March 6, 2025, reporting for the month of March 2025. The company is a foreign private issuer based in Suzhou, Jiangsu, China, and is required to file annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Ascentage Pharma is fulfilling its SEC reporting obligations as a foreign private issuer. It does not provide new operational or financial information.
Risk Assessment
Risk Level: low — This is a routine SEC filing (Form 6-K) that does not contain new material information, financial results, or strategic updates.
Key Players & Entities
- ASCENTAGE PHARMA GROUP INTERNATIONAL (company) — Filer
- 0002023311 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-42484 (company) — SEC File Number
- 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU, JIANGSU CHINA (company) — Business and Mail Address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
What is Ascentage Pharma Group International's SIC code?
Ascentage Pharma Group International's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's principal executive office address?
The company's principal executive office is located at 68 Xinqing Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Does Ascentage Pharma file annual reports under Form 20-F or 40-F?
Ascentage Pharma indicates it files annual reports under cover of Form 20-F.
What period does this 6-K filing cover?
This Form 6-K filing is for the month of March 2025, with the report period ending March 5, 2025, and filed as of March 6, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 6, 2025 regarding ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).